Literature DB >> 33389601

Effects of Melatonin and Adrenomedullin in Reducing the Cardiotoxic Effects of Doxorubicin in Rats.

Gulcin Durdagi1, Deniz Yildiz Pehlivan2, Eser Oz Oyar2, Selen Akyol Bahceci3, Mustafa Ozbek4.   

Abstract

The main disadvantage of doxorubicin (DOX) is that it has cardiotoxic side effects. Our aim is to evaluate the cardioprotective effects of adrenomedullin (ADM) and to compare these effects with melatonin (MEL), it's cardioprotective effects are well known. Rats were divided into four groups: Control group (0.9% NaCl solution, intravenously), Doxorubicin group (45 mg/kg DOX, intravenously), Doxorubicin + Melatonin group (DOX + MEL, 10 mg/kg melatonin, intraperitoneally), Doxorubicin + Adrenomedullin group (DOX + ADM, 12 µg/kg adrenomedullin, intraperitoneally). A single dose of DOX was injected to the experimental groups on day 5, and a single dose of 0.9% NaCl solution was injected to the control group through the tail vein. The animals were anesthetized and ECG recordings were obtained on day 8. For the purpose of biochemical and histological analysis, cardiac tissue biopsy was obtained after ECG recordings. Compared to the control group, the DOX group had significantly increased duration of QRS complex, PR interval, QT interval and QTc interval. QRS complex, QT interval and QTc interval were prolonged with the administration of DOX and shortened with the administration of ADM. MEL weakened the toxic effects of DOX on the cardiac tissue and it is shown histologically. DOX increased interleukins (IL-1α, IL-6, IL-18), tumor necrosis factor-α (TNF-α), hypoxia-inducible factor 1-alpha (HIF-1α), malondialdehyde (MDA), nitric oxide (NO), creatine kinase myocardial band (CK-MB), and total oxidant status (TOS) levels in cardiac tissue, while reducing total antioxidant status (TAS), superoxide dismutase (SOD) and catalase (CAT) levels. MEL administration decreased the levels of CK-MB, MDA, IL-1α, IL-6, IL-18, NO, and TNF-α, whereas ADM only decreased IL-1α, IL-18, MDA and TNF-α levels. In summary, these results show that DOX has toxic effects on rat cardiac tissue which is documented histologically, electrocardiographically and biochemically. MEL alleviated histological damage and showed improvement on the several biochemical parameters of cardiac tissue. ADM brought several electrocardiographic and biochemical parameters closer to normal values.

Entities:  

Keywords:  Adrenomedullin; Antioxidants; Cardiotoxicity; Doxorubicin; ECG; Melatonin

Mesh:

Substances:

Year:  2021        PMID: 33389601     DOI: 10.1007/s12012-020-09625-y

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  42 in total

Review 1.  Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin.

Authors:  Russel J Reiter; Sergio D Paredes; Lucien C Manchester; Dan-Xian Tan
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Jul-Aug       Impact factor: 8.250

Review 2.  Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease.

Authors:  Giuseppe Paradies; Giuseppe Petrosillo; Valeria Paradies; Russel J Reiter; Francesca M Ruggiero
Journal:  J Pineal Res       Date:  2010-05       Impact factor: 13.007

Review 3.  Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature.

Authors:  J Wojtacki; E Lewicka-Nowak; K Leśniewski-Kmak
Journal:  Med Sci Monit       Date:  2000 Mar-Apr

4.  Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply.

Authors:  Malgorzata Tokarska-Schlattner; Michael Zaugg; Rafaela da Silva; Eliana Lucchinetti; Marcus C Schaub; Theo Wallimann; Uwe Schlattner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-03-11       Impact factor: 4.733

Review 5.  Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.

Authors:  Genzou Takemura; Hisayoshi Fujiwara
Journal:  Prog Cardiovasc Dis       Date:  2007 Mar-Apr       Impact factor: 8.194

6.  Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment.

Authors:  Shashi Raj; Vivian I Franco; Steven E Lipshultz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-06

Review 7.  Cardiomyocyte death in doxorubicin-induced cardiotoxicity.

Authors:  Yi-Wei Zhang; Jianjian Shi; Yuan-Jian Li; Lei Wei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-10-29       Impact factor: 4.291

8.  Melatonin as an effective protector against doxorubicin-induced cardiotoxicity.

Authors:  Xuwan Liu; Zhongyi Chen; Chu Chang Chua; Yan-Shan Ma; George A Youngberg; Ronald Hamdy; Balvin H L Chua
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-07       Impact factor: 4.733

9.  Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis.

Authors:  D A Lowes; N R Webster; M P Murphy; H F Galley
Journal:  Br J Anaesth       Date:  2013-02-04       Impact factor: 9.166

Review 10.  Effects of melatonin on cardiovascular diseases: progress in the past year.

Authors:  Hang Sun; Aaron M Gusdon; Shen Qu
Journal:  Curr Opin Lipidol       Date:  2016-08       Impact factor: 4.776

View more
  2 in total

1.  Curcumin Ameliorates Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity Via Suppressing Oxidative Stress and Modulating iNOS, NF-κB, and TNF-α in Rats.

Authors:  Ghadha Ibrahim Fouad; Kawkab A Ahmed
Journal:  Cardiovasc Toxicol       Date:  2021-11-27       Impact factor: 3.231

2.  LCZ696 ameliorates doxorubicin-induced cardiomyocyte toxicity in rats.

Authors:  Toru Miyoshi; Kazufumi Nakamura; Naofumi Amioka; Omer F Hatipoglu; Tomoko Yonezawa; Yukihiro Saito; Masashi Yoshida; Satoshi Akagi; Hiroshi Ito
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.